Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Desvenlafaxine and Venlafaxine Exert Minimal In Vitro Inhibition of Human Cytochrome P450 and P-Glycoprotein Activities
1
x
$
30.00
Divalproex in the Treatment of Migraine
1
x
$
30.00
Possible Lurasidone-Associated Dose-Dependent QTc Prolongation in First-Episode Psychosis
1
x
$
30.00
Does Isotretinoin Cause Depression and Suicide? By J. Douglas Bremner, MD
1
x
$
0.00
Unmet Needs in the Treatment of Anxiety Disorders
1
x
$
30.00
J. Douglas Bremner, MD: Functional Neuroanatomical Correlates of Traumatic Stress Revisited 7 Years Later, This Time with Data
1
x
$
30.00
Resúmenes recientes del XXI Congreso Latinoamericano de Psiquiatria/XVI Congreso Nacional de Psiquiatría, Lima, Perú en Psiquiatría, Neurología, y Medicina General
1
x
$
0.00
Raising the Expectations of Long-Term Treatment Strategies in Anxiety Disorders
1
x
$
30.00
Pharmacy Practice: An Update on Cancer Chemoprevention
1
x
$
0.00
Pharmacokinetics, Drug Interactions, and Tolerability of Paroxetine and Paroxetine CR
1
x
$
30.00
Patient Outcomes With Education, Drug Therapy, and Support: A Study of Venlafaxine ER-Treated Outpatients with Major Depressive Disorder
1
x
$
30.00
James H. Kocsis, MD: Continuation Treatment of Chronic Depression: A Comparison of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and Their Combination
1
x
$
30.00
View Cart
Checkout
Home
Store
“James H. Kocsis, MD: Continuation Treatment of Chronic Depression: A Comparison of Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and Their Combination” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Quetiapine XR Negative Clinical Trials Report by Gang Wang
$
30.00
Add to cart
Details
Antipsychotics Case Study by Yuan-Hwa Chou
$
30.00
Add to cart
Details
Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj
$
30.00
Add to cart
Details
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$
30.00
Add to cart
Details
Roland Kuhn-100th Birthday of an Innovator of Clinical Psychopharmacology
$
30.00
Add to cart
Details
Quetiapine XR Randomized, Double-Blind Study by Arifulla Khan
$
30.00
Add to cart
Details
Ramelteon for Insomnia Related to (ADHD) by Rachel E. Fargason
$
30.00
Add to cart
Details
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
$
30.00
Add to cart
Details
Zonisamide for Bipolar Depression by Deborah Dauphinais
$
30.00
Add to cart
Details
Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams
$
30.00
Add to cart
Details
Atomoxetine Induced Hypothermia by Onat Yilmaz
$
30.00
Add to cart
Details
Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais
$
30.00
Add to cart
Details
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Clozapine Factors in Schizophrenia by Takefumi Suzuki
$
30.00
Add to cart
Details
Test of Treatment in Psychiatric Practice by Feras Ali Mustafa
$
30.00
Add to cart
Details
Clozapine Related Suicidal Obsession by Branka Aukst-Margetic
$
30.00
Add to cart
Details
Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj
$
30.00
Add to cart
Details
What Mood Symptoms may be most Difficult to Rate?
$
30.00
Add to cart
Details
Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3
$
30.00
Add to cart
Details
Assessment of Anxiety in Clinical Trials with Depressed Patients
$
30.00
Add to cart
Details
1
2
…
44
Next
Page load link
Go to Top
